Chest
Prevention of Venous Thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Section snippets
1.0 Introduction
This article systematically reviews the literature related to the risks of venous thromboembolism (VTE) and its prevention. Other evidence-based reviews are also available.123
2.1 General surgery
In studies published between 1969 and 1984,4077174 the observed rate of DVT among general surgical patients not receiving prophylaxis varied between 15% and 30%, with rates of fatal PE between 0.2% and 0.9%.The current risk of thromboembolic complications in general surgery is unknown because studies without prophylaxis are no longer performed in these patients. More rapid mobilization, greater use of thromboprophylaxis, and other advances in perioperative care may tend toward reducing the
3.0 Orthopedic Surgery
Patients undergoing major orthopedic surgery, which includes hip and knee arthroplasty and hip fracture repair, represent a group that is at particularly high risk for VTE, and routine thromboprophylaxis has been the standard of care for > 15 years.2331 Randomized clinical trials have demonstrated that the rates of venographic DVT and proximal DVT 7 to 14 days following major orthopedic surgery in patients who received no prophylaxis are approximately 40 to 60% and 10 to 30%, respectively (
4.0 Neurosurgery
Patients undergoing major neurosurgery are known to be at moderately increased risk of postoperative VTE and warrant the routine use of thromboprophylaxis.2539540541542 In several randomized clinical trials, which included a spectrum of neurosurgery patients, the rate of DVT, detected by FUT, among the control subjects was 22%, with a rate of proximal DVT of 5%.2 The risk factors for DVT in neurosurgery patients include intracranial surgery (rather than spinal surgery), active malignancy, more
5.1 Trauma
Among hospitalized patients, those recovering from major trauma have the highest risk of developing VTE.262563564565 Without prophylaxis, patients with multisystem or major trauma have a DVT risk exceeding 50%,262566 with PE being the third leading cause of death in those who survive beyond the first day.62567568569570 In a prospective study of 443 major trauma patients not receiving any thromboprophylaxis, who had undergone routine bilateral contrast venography, the rates of DVT and proximal
6.0 Medical Conditions
Although VTE is most often considered to be associated with recent surgery or trauma, 50 to 70% of symptomatic thromboembolic events677678 and 70 to 80% of fatal PEs121721679680681 occur in nonsurgical patients. Hospitalization for an acute medical illness is independently associated with about an eightfold increased relative risk for VTE499 and accounts for almost one quarter of all VTE events within the general population.9 Thus, the appropriate prophylaxis of medical inpatients offers an
7.0 Cancer Patients
Patients with cancer have a sixfold increased risk of VTE compared to those without cancer.499 Active cancer accounts for almost 20% of all new VTE events occurring in the community.9 Furthermore, VTE is one of the most common complications seen in cancer patients.715716 Unfortunately, there are few data that allow one to predict which cancer patients will develop VTE. The risk varies by cancer type, and is especially high among patients with malignant brain tumors and adenocarcinoma of the
8.0 Critical Care
Two systematic reviews of VTE and its prevention in critical care settings632748 have been published in the past few years. Most critically ill patients have multiple risk factors for VTE.748749750 Some of these risk factors predate admission to the ICU, and include recent surgery, trauma, sepsis, malignancy, immobilization, stroke, advanced age, heart or respiratory failure, previous VTE, and pregnancy. Other thrombotic risk factors may be acquired during an ICU stay, and include
9.0 Long Distance Travel
Despite extensive lay press coverage, the evidence for an association between prolonged travel, whether by air or by land, and VTE remains controversial.512765766767768769770771772773774 Retrospective studies512765771775 have suggested that approximately 4 to 20% of patients presenting with VTE had traveled within a few weeks prior to the event. One study776 found an increased risk of VTE that was present only for the first 2 weeks after arrival from a long-haul flight. The incidence of
Summary of Recommendations
1.0 General Recommendations
1.4.3. We recommend that mechanical methods of prophylaxis be used primarily in patients who are at high risk of bleeding (Grade 1C+) or as an adjunct to anticoagulant-based prophylaxis (Grade 2A). We recommend that careful attention be directed toward ensuring the proper use of, and optimal compliance with, the mechanical device (Grade 1C+).
1.4.4. We recommend against the use of aspirin alone as prophylaxis against VTE for any patient group (Grade 1A).
1.4.5.1. For each of the antithrombotic
2.1 General surgery
2.1.1. In low-risk general surgery patients (Table 5) who are undergoing a minor procedure, are < 40 years of age, and have no additional risk factors, we recommend against the use of specific prophylaxis other than early and persistent mobilization (Grade 1C+).
2.1.2. Moderate-risk general surgery patients are those patients undergoing a nonmajor procedure and are between the ages of 40 and 60 years or have additional risk factors, or those patients who are undergoing major operations and are <
3.1 Elective hip arthroplasty
3.1.1. For patients undergoing elective THR, we recommend the routine use of one of the following three anticoagulants: (1) LMWH (at a usual high-risk dose, started 12 h before surgery or 12 to 24 h after surgery, or 4 to 6 h after surgery at half the usual high-risk dose and then increasing to the usual high-risk dose the following day); (2) fondaparinux, (2.5 mg started 6 to 8 h after surgery) or (3) adjusted-dose VKA started preoperatively or the evening after surgery (INR target, 2.5; INR
4.0 Neurosurgery
4.0.1. We recommend that thromboprophylaxis be routinely used in patients undergoing major neurosurgery (Grade 1A).
4.0.2. We recommend the use of IPC with or without GCS in patients undergoing intracranial neurosurgery (Grade 1A).
4.0.3. Acceptable alternatives to the above options are prophylaxis with LDUH (Grade 2B) or postoperative LMWH (Grade 2A).
4.0.4. We suggest the combination of mechanical prophylaxis (ie, GCS and/or IPC) and pharmacologic prophylaxis (ie, LDUH or LMWH) in high-risk
5.1 Trauma
5.1.1. We recommend that all trauma patients with at least one risk factor for VTE receive thromboprophylaxis, if possible (Grade 1A).
5.1.2. In the absence of a major contraindication, we recommend that clinicians use LMWH prophylaxis starting as soon as it is considered safe to do so (Grade 1A).
5.1.3. We recommend that mechanical prophylaxis with IPC, or possibly with GCS alone, be used if LMWH prophylaxis is delayed or if it is currently contraindicated due to active bleeding or a high risk
6.0 Medical conditions
6.0.1. In acutely ill medical patients who have been admitted to the hospital with congestive heart failure or severe respiratory disease, or who are confined to bed and have one or more additional risk factors, including active cancer, previous VTE, sepsis, acute neurologic disease, or inflammatory bowel disease, we recommend prophylaxis with LDUH (Grade 1A) or LMWH (Grade 1A).
6.0.2. In medical patients with risk factors for VTE, and in whom there is a contraindication to anticoagulant
7.0 Cancer patients
7.0.1. We recommend that cancer patients undergoing surgical procedures receive prophylaxis that is appropriate for their current risk state (Grade 1A). Refer to the recommendations in the relevant surgical subsections.
7.0.2. We recommend that hospitalized cancer patients who are bedridden with an acute medical illness receive prophylaxis that is appropriate for their current risk state (Grade 1A). Refer to the recommendations in the section dealing with medical patients.
7.0.3. We suggest that
8.0 Critical care
8.1. We recommend that, on admission to a critical care unit, all patients be assessed for their risk of VTE. Accordingly, most patients should receive thromboprophylaxis (Grade 1A).
8.2. For patients who are at high risk for bleeding, we recommend mechanical prophylaxis with GCS and/or IPC until the bleeding risk decreases (Grade 1C+).
8.3. For ICU patients who are at moderate risk for VTE (eg, medically ill or postoperative patients), we recommend using LDUH or LMWH prophylaxis (Grade 1A).
8.4.
9.0 Long distance travel
9.1. We recommend the following general measures for long-distance travelers (ie, flights of > 6 h duration): avoidance of constrictive clothing around the lower extremities or waist; avoidance of dehydration; and frequent calf muscle stretching (Grade 1C).
9.2. For long-distance travelers with additional risk factors for VTE, we recommend the general strategies listed above. If active prophylaxis is considered, because of the perceived increased risk of venous thrombosis, we suggest the use of
ACKNOWLEDGMENT
We are grateful to the following external experts who reviewed specific subsections of this article (or the entire article = *) and provided written comments: W. Ageno (Varese, Italy); D. Anderson (Halifax, NS, Canada); R. Arya (London, UK); G. Belcaro (San Valentino, Italy); J.-F. Bergmann (Paris, France); F. Brenneman (Toronto, ON, Canada); R. Buckley (Calgary, AB, Canada); D. Cannavo (New York, NY); J. Caprini (Chicago, IL); M. Cipolle (Allentown, PA); D. Clarke-Pearson (Durham, NC); P. Comp
References (794)
- et al.
Prevention of venous thromboembolism
Chest
(2001) - et al.
Methodology for guideline development for the Seventh American College of Chest Physicians conference on antithrommbotic and thrombolytic therapy
Chest
(2004) Venous thrombosis: a multicausal disease
Lancet
(1999)- et al.
Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy
Chest
(1995) - et al.
Natural history of postoperative deep-vein thrombosis
Lancet
(1969) - et al.
Lower extremity calf thrombosis: to treat or not to treat?
J Vasc Surg
(1991) - et al.
V/Q defects and deep venous thrombosis following total hip replacement
Clin Radiol
(1995) - et al.
Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials
Lancet
(2001) - et al.
Factors associated with correct antemortem diagnosis of major pulmonary embolism
Am J Med
(1982) - et al.
Clinical recognition of pulmonary embolism: problems of unrecognized and asymptomatic cases
Mayo Clin Proc
(1998)
Complications of subcutaneous low-dose heparin therapy in neurosurgical patients
Surg Neurol
Long-term hemodynamic and clinical sequellae of lower extremity deep vein thrombosis
J Vasc Surg
Trends in the incidence of venous stasis syndrome and venous ulcer: a 25-year population-based study
J Vasc Surg
Economic burden of long-term complications of deep vein thrombosis after total hip replacement surgery in the United States
Value Health
Cost-effectiveness of prophylaxis in total hip replacement
Am J Surg
Surveillance venous scans for deep venous thrombosis in multiple trauma patients
Ann Vasc Surg
Prevention of venous thrombosis and pulmonary embolism in injured patients: a trial of anticoagulant prophylaxis with phenindione in middle-aged and elderly patients with fractured necks of femur
Lancet
Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis
Lancet
Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery
Lancet
Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis: meta-analysis based on original patient data
Thromb Res
The use of fibrinogen uptake test in screening for deep vein thrombosis in patients with hip fracture
Thromb Res
Risk of and prophylaxis for venous thromboembolism in hospital patients
Phlebology
Prophylaxis of venous thromboembolism: a national clinical guideline. 2002; SIGN Publication No. 62
Measuring the outcomes and pharmacoeconomic consequences of venous thromboembolism prophylaxis in major orthopaedic surgery
Pharmacoeconomics
The prevalence of risk factors for venous thromboembolism among hospital patients
Arch Intern Med
Risk factors for venous thrombotic disease
Thromb Haemost
Epidemiology, pathogenesis, and natural history of venous thrombosis
Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study
Arch Intern Med
Risk factors for venous thromboembolism
Circulation
A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study
Arch Intern Med
Complications after low-back fusion in 1000 patients: a comparison of two series one decade apart
J Bone Joint Surg Am
Autopsy-verified pulmonary embolism in a surgical department: analysis of the period from 1951 to 1968
Br J Surg
Differences in mortality after fracture of hip: the East Anglian audit
BMJ
Fatal pulmonary embolism in hospitalised medical patients
J Clin Pathol
Mortality and fatal pulmonary embolism after primary total hip replacement: results from a regional hip register
J Bone Joint Surg Br
Complications of spinal fusion in treatment of adult spinal deformity [abstract]
Spine J
Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures
Thromb Haemost
Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis?
J R Soc Med
Indications for the treatment of deep venous thrombosis following total knee replacement
J Bone Joint Surg Am
Calf deep venous thrombosis: a wolf in sheep's clothing?
Arch Intern Med
Features of thrombi and diagnostic accuracy of impedance plethysmography in symptomatic and asymptomatic deep vein thrombosis
Thromb Haemost
Postoperative venous thrombosis in benign prostatic disease: a study of 316 patients, using the125I-fibrinogen uptake test
Scand J Urol Nephrol Suppl
Progression and regression of deep vein thrombosis after total knee arthroplasty
Clin Orthop
Is anticoagulation indicated for asymptomatic postoperative calf vein thrombosis?
J Vasc Surg
Natural history of venous thromboembolism
Circulation
Femoral vein thrombosis and total hip replacement
BMJ
An evaluation of impedance plethysmography and125I-fibrinogen leg scanning in patients following hip surgery
Thromb Haemost
Distribution and occlusiveness of thrombi in patients with surveillance detected deep vein thrombosis after hip surgery
Thromb Haemost
Relevance of venographic distal thrombus assessment in venous thromboembolism (VTE) prophylaxis studies: lessons from the fondaparinux (Arixtra) database in major orthopedic surgery [abstract]
J Thromb Haemost
Is embolic risk conditioned by location of deep venous thrombosis?
Ann Intern Med
Cited by (2914)
Factors associated with perioperative deep vein thrombosis in arthroscopic anterior cruciate ligament reconstruction
2023, Journal of Orthopaedic SciencePrevention of venous thromboembolic disease in medical patient
2023, Medicina ClinicaAspirin prophylaxis is not associated with increased risk of venous thromboembolism in arthroplasty for femoral neck fractures: a non-inferiority study
2024, European Journal of Orthopaedic Surgery and Traumatology